Private Equity
UK-based ReViral, an antiviral drug discovery and development company, has closed $55 million in Series B financing. New Leaf Venture Partners and Novo Ventures led the round with participation from Perceptive Advisors, Andera Partners, OrbiMed and Brace Pharma Capital. In conjunction with the financing, representatives of New Leaf Ventures and Novo Ventures will join the ReViral board of directors.
1 min read · 01 August 2018
San Mateo, California-based Evidation Health, a health and measurement company, has raised $30 million in Series C funding. SV Health Investors and B Capital Group led the round with participation from existing investors GE Ventures and Sanofi Ventures.
1 min read · 01 August 2018
San Francisco-based Mammoth Biosciences, which develops CRISPR-based disease detection platform, announced it has raised $23 million in Series A funding. Mayfield led the round, which included participation from NFX and 8VC. The company, which was founded in 2017 and came out of stealth mode earlier this year, previously raised seed funding from NFX.
1 min read · 01 August 2018
4 min read · 31 July 2018
We had a great turnout for Emerging Manager Connect East conference last Thursday at the Grand Hyatt in New York City. We’ve loaded 35 photos from the event to a photo album in our PE Hub Network page on Facebook. Check them out here. And don’t forget to “like” our page while you’re there!
1 min read · 31 July 2018
San Diego-based Omniome Inc, a developer of a new DNA sequencing platform, has raised $60 million in financing. Decheng Capital and Hillhouse Capital Group led the round with participation from Lam Research Capital, Nan Fung Life Sciences, ARCH Venture Partners, Domain Associates, Biomatics Capital Partners and Altitude Life Science Ventures.
1 min read · 31 July 2018
1 min read · 31 July 2018
Strawberry Creek Ventures is seeking to raise $4 million for its maiden fund, according to an SEC filing. Strawberry Creek Ventures is a venture fund for alumni of University of California, Berkeley that invests in companies with a UC Berkeley connection.
1 min read · 31 July 2018
Verana Health, a healthcare innovation platform, has raised $30 million in Series C financing. GV led the round with participation from return backers Biomatics Capital, Brook Byers, GE Ventures and Lagunita Biosciences. In addition to the funding, Verana Health has appointed Miki Kapoor as president and CEO.
1 min read · 31 July 2018
2 min read · 31 July 2018
